The vaccine trial is on track. Last Friday, on 9 October, the first test subject was injected with the vaccine MVA-SARS-2-S against COVID-19. A total of six volunteers received the vector vaccine to
Please use this picture in combination with the press release.
Healthcare-associated infections have been growing continuously for years, resulting in hundreds of thousands of avoidable deaths each year. The main culprit is bacteria that have become resistant to
Please use this picture only in connection with the press release.
The Paul-Ehrlich-Institut, the Federal Institute for Vaccines and Biomedicines, today approved the clinical trial of the MVA-SARS-2-S vaccine against COVID-19. The vector vaccine was developed by
The DZIF Academy is pleased to open the call for applications for two prizes in 2020: the DZIF Prize for Fundamental Translational Infection Research and the DZIF Prize for Clinical Translational
An international team managed by scientists at the Research Center Borstel and the German Center for Infection Research (DZIF) have examined a new method for detecting resistant tuberculosis strains
Bonn, 6. August 2020. Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction – rather, the immune response is caught in a
Who has overcome an infection with the virus without noticing, and how many people have already produced protective antibodies against the new coronavirus? Various antibody studies are now under way
The smallpox virus was already circulating in Northern Europe in the 7th century. This is indicated by DNA from Viking skeletons that researchers from Charité - Universitätsmedizin Berlin, including
A research team from the University of Tübingen and the German Center for Infection Research (DZIF) is investigating how pathogens influence the immune response of their host with genetic variation
